NeOnc Technologies Holdings

NTHI · NASDAQ

$2.77+$0.05 (+1.84%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $2.72

Latest news

Press releaseOct 20, 9:33 AM ETGlobe Newswire
Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season
Press releaseOct 16, 8:56 AM ETGlobe Newswire
NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone
Press releaseOct 16, 8:00 AM ETGlobe Newswire
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi
Press releaseOct 15, 9:35 AM ETGlobe Newswire
From Shaq to Musk: The Power Appointment Effect
Press releaseOct 15, 8:57 AM ETGlobe Newswire
UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances
Press releaseOct 15, 8:00 AM ETGlobe Newswire
NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026
Press releaseOct 14, 10:18 AM ETGlobe Newswire
NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug Development
Press releaseOct 14, 8:00 AM ETGlobe Newswire
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors
Press releaseOct 7, 9:59 AM ETGlobe Newswire
2026 Takes a Promising Turn in the Fight Against Cancer as Five Advances Offer New Hope
Press releaseOct 7, 9:43 AM ETGlobe Newswire
NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer
Press releaseOct 6, 9:02 AM ETGlobe Newswire
NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt
Press releaseOct 5, 9:51 AM ETGlobe Newswire
Biotech Brainiacs and Breakthroughs
Press releaseOct 2, 11:44 AM ETGlobe Newswire
These High-Voltage Stocks Are Suddenly Impossible to Ignore
Press releaseSep 30, 10:22 AM ETGlobe Newswire
3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours
Press releaseSep 29, 12:12 PM ETGlobe Newswire
High-Stakes October has these Biotechs Entering Crucial Stretch
Press releaseSep 29, 8:52 AM ETGlobe Newswire
NeOnc’s Powerful Brain Cancer Pipeline Advances
Press releaseSep 28, 11:51 AM ETGlobe Newswire
4 Explosive Stories Enter the Investor Spotlight
Press releaseSep 28, 9:51 AM ETGlobe Newswire
Powerful NeOnc Brain Cancer Pipeline Advances
Press releaseSep 24, 11:43 AM ETGlobe Newswire
Here’s What Investors Are Watching, Including $20 Price Target Bombshell
Press releaseSep 24, 10:20 AM ETGlobe Newswire
NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
Press releaseSep 22, 2:52 PM ETGlobe Newswire
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier
Press releaseSep 22, 10:31 AM ETGlobe Newswire
Today’s Best Stocks to Watch: Weight-Loss Wars, Biotech and Critical Minerals
Press releaseSep 21, 8:00 AM ETGlobe Newswire
NeOnc Charting New Nasal Route to Treating Brain Cancer
Press releaseSep 17, 11:37 AM ETGlobe Newswire
Four High-Impact Small Caps Enter the Spotlight
Press releaseSep 17, 8:54 AM ETGlobe Newswire
NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates
Press releaseSep 16, 8:46 AM ETGlobe Newswire
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
Press releaseSep 15, 9:53 AM ETGlobe Newswire
Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus
Press releaseSep 14, 9:07 AM ETGlobe Newswire
Insiders Continue Buying, as NeOnc Moves NEO100 Toward Its Next Regulatory Test
Press releaseAug 14, 1:13 PM ETGlobe Newswire
These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started
NewsAug 14, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 12, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseAug 11, 2:44 PM ETGlobe Newswire
Breakout Stocks and Next Big Movers Could Be Taking Shape Now
Press releaseAug 11, 11:00 AM ETGlobe Newswire
NeOnc Approaches a Major Biotech Inflection Point as tomorrow’s Brain-Cancer Data is set to Collide with a Tight Float
NewsAug 11, 8:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsJul 16, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseJun 12, 11:40 AM ETGlobe Newswire
From Nokia to NeOnc: The Stocks Dominating Screens as Volume Spikes
NewsFeb 11, 4:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsFeb 10, 4:05 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsJul 29, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season

NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone

NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi

From Shaq to Musk: The Power Appointment Effect

UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances

NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026

NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug Development

NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors

2026 Takes a Promising Turn in the Fight Against Cancer as Five Advances Offer New Hope

NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer

NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt

Biotech Brainiacs and Breakthroughs

These High-Voltage Stocks Are Suddenly Impossible to Ignore

3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours

High-Stakes October has these Biotechs Entering Crucial Stretch

NeOnc’s Powerful Brain Cancer Pipeline Advances

4 Explosive Stories Enter the Investor Spotlight

Powerful NeOnc Brain Cancer Pipeline Advances

Here’s What Investors Are Watching, Including $20 Price Target Bombshell

NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst

NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier

Today’s Best Stocks to Watch: Weight-Loss Wars, Biotech and Critical Minerals

NeOnc Charting New Nasal Route to Treating Brain Cancer

Four High-Impact Small Caps Enter the Spotlight

NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates

NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA

Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus

Insiders Continue Buying, as NeOnc Moves NEO100 Toward Its Next Regulatory Test

These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Breakout Stocks and Next Big Movers Could Be Taking Shape Now

NeOnc Approaches a Major Biotech Inflection Point as tomorrow’s Brain-Cancer Data is set to Collide with a Tight Float

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

From Nokia to NeOnc: The Stocks Dominating Screens as Volume Spikes

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session